From October 2016 to March 2017 the team is joined by Guest Kats Rosie Burbidge and Eibhlin Vardy, and by InternKats Verónica Rodríguez Arguijo, Tian Lu and Hayleigh Bosher.

Monday, 19 December 2005

PFIZER WINS US LIPITOR PATENT CASE

Reuters reports that generic drug manufacturer Ranbaxy has failed in its attempt to get Pfizer’s US patents in its LIPITOR anti-cholesterol drug invalidated. The decision by a US federal judge means that Ranbaxy cannot launch a generic version of LIPITOR at present. As a result, its share price has dropped by almost 9%, while the share prices of big pharmaceutical companies, including some that were not involved in the litigation, have risen. Ranbaxy have announced that it intends to appeal.


The IPKat notes that this result mirrors Pumfrey J’s decision to uphold the validity of the UK patents for LIPITOR held by Pfizer in October.

No comments:

Subscribe to the IPKat's posts by email here

Just pop your email address into the box and click 'Subscribe':